The basis of this project is the Translational Core Laboratory and Industry-Academia Collaboration and Incubation platform. With the objective of originating enterprise, current project aims to industrialize the research products by the experienced professionals; meanwhile, in order to transfer academia intellectual property into everlasting energy of managing Taipei Medical University, current project establishes the atmosphere of initiating a business creatively and incubates senior experts in the field of biotechnology actively. Taipei Medical University (TMU) is orientated by becoming one of the top research university on the basis of translational medicine. We plan budget annually to recruit distinguishing research team, to provide financial support at the primary stage, and to accelerate the development of potential marker with clinical translational values. With the translational medical core laboratory, we are able to optimize pharmaceuticals, evaluate the pharmacy, establish biobank and clinical research database, construct biomedical equipment manufacturing center and GTP laboratory in addition to the only early-stage clinical trial ward nationwide. Besides, Taipei Medical University has always been enjoying its reputation as an excellent partner of industryacademia collaboration in the field of biomedical science. Our executant team comprises experts from the biomedical field who is responsible for the protection of intellectual property, licensing of technology, and cooperation between industry and academia. Through the translational research core facility and industry-academia collaboration, the gap among basic research, pre-clinical research, clinical research, and the production development can be connected to boost the research development and industrialize the research product.
|Effective start/end date||8/1/17 → 7/31/18|
- SPARK Taiwan
- Biomedical commercialization
- Technology transfer
- Clinical trial